Abstract
Intercellular communication plays a pivotal role in various physiological functions. This is mainly done through gap junctions and trans-membrane channels. The structural proteins forming these channels are different in vertebrates and invertebrates namely connexins and innexins respectively. Recently, a new class of proteins playing a crucial role in intercellular communication was discovered and named pannexins. They are found to have similar homology to innexins. Earlier they were also thought to form gap junctions and hemi channels on oppositional cell surfaces like connexins but later they were found to have different structure, location and function than connexins. Their main role is in the initiation and propagation of cellular calcium waves and ATP release. They are also considered an integral part of the greater purinergic and adrenergic receptor complexes. They are implicated in wide variety of biochemical and pathophysiological functions ranging from apoptosis, inflammation, ischemia, seizures and immune response; to paracrine signaling, vasodymanics, tumor genesis, cellular differentiation and development. Due to their ubiquitous distribution and involvement in myriad cellular functions, they are considered as potential therapeutic targets for diseases like hypertension, epilepsy and immune disorders.
Keywords: Calcium, cellular communication, purine, hypertension, channels.
Current Drug Targets
Title:Pannexin Channels: The Emerging Therapeutic Targets
Volume: 15 Issue: 3
Author(s): Misbahuddin Mohammad and Hamed Said Habib
Affiliation:
Keywords: Calcium, cellular communication, purine, hypertension, channels.
Abstract: Intercellular communication plays a pivotal role in various physiological functions. This is mainly done through gap junctions and trans-membrane channels. The structural proteins forming these channels are different in vertebrates and invertebrates namely connexins and innexins respectively. Recently, a new class of proteins playing a crucial role in intercellular communication was discovered and named pannexins. They are found to have similar homology to innexins. Earlier they were also thought to form gap junctions and hemi channels on oppositional cell surfaces like connexins but later they were found to have different structure, location and function than connexins. Their main role is in the initiation and propagation of cellular calcium waves and ATP release. They are also considered an integral part of the greater purinergic and adrenergic receptor complexes. They are implicated in wide variety of biochemical and pathophysiological functions ranging from apoptosis, inflammation, ischemia, seizures and immune response; to paracrine signaling, vasodymanics, tumor genesis, cellular differentiation and development. Due to their ubiquitous distribution and involvement in myriad cellular functions, they are considered as potential therapeutic targets for diseases like hypertension, epilepsy and immune disorders.
Export Options
About this article
Cite this article as:
Mohammad Misbahuddin and Habib Said Hamed, Pannexin Channels: The Emerging Therapeutic Targets, Current Drug Targets 2014; 15 (3) . https://dx.doi.org/10.2174/13894501113146660217
DOI https://dx.doi.org/10.2174/13894501113146660217 |
Print ISSN 1389-4501 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-5592 |
Call for Papers in Thematic Issues
New drug therapy for eye diseases
Eyesight is one of the most critical senses, accounting for over 80% of our perceptions. Our quality of life might be significantly affected by eye disease, including glaucoma, diabetic retinopathy, dry eye, etc. Although the development of microinvasive ocular surgery reduces surgical complications and improves overall outcomes, medication therapy is ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
PPAR Modulators and PPAR Pan Agonists for Metabolic Diseases: The Next Generation of Drugs Targeting Peroxisome Proliferator-Activated Receptors?
Current Topics in Medicinal Chemistry Editorial [Hot Topic: Complications in Pregnancy - Recent Developments in Preventive Strategies and Treatment Modalities (Executive Editor: A.C. Bolte)]
Current Pharmaceutical Design Angiotensin II and the Cardiac Complications of Diabetes Mellitus
Current Pharmaceutical Design Isometric Handgrip Effects on Hypertension
Current Hypertension Reviews Editorial (Thematic Issue: Induced Pluripotent Stem Cells (iPSCs) in the Gastroenterology and Hepatology: from Basic Research to Clinical Applications)
Current Stem Cell Research & Therapy Disease Registries: Challenges and Opportunities to Realize Their Full Potential
Applied Clinical Research, Clinical Trials and Regulatory Affairs Validation of Two High-Performance Liquid Chromatographic Methods for the Analysis of Nadolol and Propranolol Hydrochloride Following In Vitro Transdermal Diffusion Studies
Current Pharmaceutical Analysis Metabolic and Cardiovascular Ageing Indices in Relation to Glycated Haemoglobin in Healthy and Diabetic Subjects
Current Aging Science Inflammation, Adipocytokines, and Atherosclerosis in the Metabolic Syndrome
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Left Ventricular Non-compaction: From Recognition to Treatment
Current Pharmaceutical Design The Dialogue Between Endothelial Cells and Monocytes/Macrophages in Vascular Syndromes
Current Pharmaceutical Design Editorial [Hot Topic: Biochemical and Clinical Relevance of Hyperuricaemia (Executive Editor: Dimitri P. Mikhailidis Associate Editor: Stella S. Daskalopoulou)]
Current Pharmaceutical Design Measurement of the Endogenous Adenosine Concentration in Humans In Vivo: Methodological Considerations
Current Drug Metabolism Collagen Cross-link Breakers:A Beginning of a New Era in the Treatment of Cardiovascular Changes Associated with Aging,Diabetes,and Hypertension
Current Drug Targets - Cardiovascular & Hematological Disorders Oxidative Stress, Preeclampsia and Cardiovascular Disease
Current Hypertension Reviews Pigment Epithelium-derived Factor (PEDF) and Cardiometabolic Disorders
Current Pharmaceutical Design Calcitonin Gene-Related Family Peptides in Vascular Adaptations, Uteroplacental Circulation, and Fetal Growth
Current Vascular Pharmacology Facing Up the ROS Labyrinth - Where To Go?
Current Vascular Pharmacology New Insight Into A1 Adenosine Receptors in Diabetes Treatment
Current Pharmaceutical Design Cardiovascular Complications in Autosomal Dominant Polycystic Kidney Disease
Current Hypertension Reviews